152 related articles for article (PubMed ID: 36441688)
1. Evaluation of emerging inflammatory markers for predicting oxygen support requirement in COVID-19 patients.
Kamjai P; Hemvimol S; Bordeerat NK; Srimanote P; Angkasekwinai P
PLoS One; 2022; 17(11):e0278145. PubMed ID: 36441688
[TBL] [Abstract][Full Text] [Related]
2. [Early prediction of severe COVID-19 in patients with Sjögren's syndrome].
Li JB; Lyu MN; Chi Q; Peng YL; Liu PC; Wu R
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1007-1012. PubMed ID: 38101781
[TBL] [Abstract][Full Text] [Related]
3. Role of NLR, PLR, ELR and CLR in differentiating COVID-19 patients with and without pneumonia.
Damar Çakırca T; Torun A; Çakırca G; Portakal RD
Int J Clin Pract; 2021 Nov; 75(11):e14781. PubMed ID: 34482573
[TBL] [Abstract][Full Text] [Related]
4. Predicting the Outcome of Patients with Severe COVID-19 with Simple Inflammatory Biomarkers: The Utility of Novel Combined Scores-Results from a European Tertiary/Referral Centre.
Ntalouka MP; Brotis A; Mermiri M; Pagonis A; Chatzis A; Bareka M; Kotsi P; Pantazopoulos I; Gourgoulianis K; Arnaoutoglou EM
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398280
[No Abstract] [Full Text] [Related]
5. Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19.
Ben Jemaa A; Salhi N; Ben Othmen M; Ben Ali H; Guissouma J; Ghadhoune H; Oueslati R; Dhaouadi H
Int Immunopharmacol; 2022 Aug; 109():108781. PubMed ID: 35461157
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of simple inflammatory biomarkers in patients with severe COVID-19: an observational study.
Ntalouka MP; Pantazopoulos I; Brotis AG; Pagonis A; Vatsiou I; Chatzis A; Rarras CN; Kotsi P; Gourgoulianis KI; Arnaoutoglou EM
Hippokratia; 2022; 26(2):70-77. PubMed ID: 37188050
[TBL] [Abstract][Full Text] [Related]
8. Use of the neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with COVID-19.
Ozawa T; Asakura T; Chubachi S; Namkoong H; Tanaka H; Lee K; Fukushima T; Otake S; Nakagawara K; Watase M; Masaki K; Kamata H; Ishii M; Hasegawa N; Harada N; Ueda T; Ueda S; Ishiguro T; Arimura K; Saito F; Yoshiyama T; Nakano Y; Mutoh Y; Suzuki Y; Edahiro R; Murakami K; Okada Y; Koike R; Kitagawa Y; Tokunaga K; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K;
Respir Investig; 2023 Jul; 61(4):454-459. PubMed ID: 37121116
[TBL] [Abstract][Full Text] [Related]
9. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
Sahin O; Aktoz F; Bagci H; Vurgun E
J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID-19 patients.
Erdogan A; Can FE; Gönüllü H
J Med Virol; 2021 Sep; 93(9):5555-5559. PubMed ID: 34019701
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
[TBL] [Abstract][Full Text] [Related]
12. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.
Lin S; Mao W; Zou Q; Lu S; Zheng S
J Clin Lab Anal; 2021 Jan; 35(1):e23604. PubMed ID: 33184946
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio and Their Role as Predictors of Disease Severity of Coronavirus Disease 2019 (COVID-19).
Jain R; Gopal A; Pathak BK; Mohakuda SS; Tilak T; Singh AR
J Lab Physicians; 2021 Mar; 13(1):58-63. PubMed ID: 34103879
[No Abstract] [Full Text] [Related]
14. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis.
Khalid A; Ali Jaffar M; Khan T; Abbas Lail R; Ali S; Aktas G; Waris A; Javaid A; Ijaz N; Muhammad N
Hematology; 2021 Dec; 26(1):529-542. PubMed ID: 34334100
[No Abstract] [Full Text] [Related]
15. Inflammation-based Indices Predicting Mortality in COVID-19.
Cakirca G; Cakirca TD; Bindal A; Olcen M
J Coll Physicians Surg Pak; 2023 Jan; 33(1):112-114. PubMed ID: 36597247
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the Relationship of Systemic Immune-Inflammation Index, C-Reactive Protein and Interleukin-6 with Viral Dynamics in Patients with COVID-19].
Salman E; Çelikbilek N; Aydoğan S; Özdem B; Gökay S; Kırca F; Toyran A; Bilici Salman R; Dinç B
Mikrobiyol Bul; 2021 Oct; 55(4):539-552. PubMed ID: 34666654
[TBL] [Abstract][Full Text] [Related]
17. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
[No Abstract] [Full Text] [Related]
19. Neutrophil to lymphocyte ratio and C-reactive protein level as prognostic markers in mild versus severe COVID-19 patients.
Mousavi-Nasab SD; Mardani R; Nasr Azadani H; Zali F; Ahmadi Vasmehjani A; Sabeti S; Alavi Darazam I; Ahmadi N
Gastroenterol Hepatol Bed Bench; 2020; 13(4):361-366. PubMed ID: 33244379
[TBL] [Abstract][Full Text] [Related]
20. The Diagnostic and Predictive Roles of Neutrophil-Lymphocyte Ratio for Severity of Disease in COVID-19 Patients.
Islamoglu MS; Borku-Uysal B; Yavuzer S; Ikitimur H; Seyhan S; Koc S; Cengiz M
Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
